BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 29431527)

  • 21. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
    Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
    Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
    Solari D; Bertero E; Miceli R; Brunelli C; Ameri P; Canepa M
    Int J Cardiol; 2017 Jun; 236():262-269. PubMed ID: 28143653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When is Device-Detected Atrial Fibrillation Actionable?
    Wasserlauf J; Passman RS
    Card Electrophysiol Clin; 2018 Mar; 10(1):75-85. PubMed ID: 29428144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
    Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
    Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.
    Hess PL; Healey JS; Granger CB; Connolly SJ; Ziegler PD; Alexander JH; Kowey PR; Ruff CT; Flaker G; Halperin JL; Hart RG; Lopes RD
    JAMA Cardiol; 2017 Mar; 2(3):324-331. PubMed ID: 28097334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
    Boriani G; Santini M; Lunati M; Gasparini M; Proclemer A; Landolina M; Padeletti L; Botto GL; Capucci A; Bianchi S; Biffi M; Ricci RP; Vimercati M; Grammatico A; Lip GY;
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):182-8. PubMed ID: 22373906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.
    Boriani G; Pettorelli D
    Vascul Pharmacol; 2016 Aug; 83():26-35. PubMed ID: 27196706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole.
    Hindricks G; Theuns DA; Bar-Lev D; Anguera I; Ayala Paredes FA; Arnold M; Geller JC; Merkely B; Dyrda KM; Perings C; Maglia G; Ploux S; Meyhöfer J; Blomström-Lundqvist C; Karjalainen P; Liang Y; Diemberger I; Wranicz JK; Barr C; Quartieri F; Timmel T; Bollmann A
    Europace; 2023 May; 25(5):. PubMed ID: 37038759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices.
    Turakhia MP; Ziegler PD; Schmitt SK; Chang Y; Fan J; Than CT; Keung EK; Singer DE
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1040-7. PubMed ID: 26175528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation.
    Miyazawa K; Pastori D; Lip GYH
    Prog Cardiovasc Dis; 2018; 60(4-5):537-541. PubMed ID: 29289494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uninterrupted non-vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation.
    Tsai CT; Liao JN; Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Tuan TC; Chen SA
    J Chin Med Assoc; 2019 Apr; 82(4):256-259. PubMed ID: 30946706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Device-detected atrial arrhythmia - when is anticoagulation indicated?].
    Almqvist M; Mattsson G; Magnusson P
    Lakartidningen; 2019 Aug; 116():. PubMed ID: 31408188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.
    Nishinarita R; Niwano S; Fukaya H; Oikawa J; Nabeta T; Matsuura G; Arakawa Y; Kobayashi S; Shirakawa Y; Horiguchi A; Nakamura H; Ishizue N; Kishihara J; Satoh A; Ako J
    Circ J; 2019 Mar; 83(4):736-742. PubMed ID: 30814400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators.
    Fawzy AM; Bisson A; Bentounes SA; Bodin A; Herbert J; Lip GYH; Fauchier L
    Eur J Intern Med; 2023 Sep; 115():70-78. PubMed ID: 37291016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.
    Shurrab M; Janmohamed A; Sarrazin JF; Ayala-Paredes F; Sturmer M; Williams R; Toal S; Lane C; Thorpe KE; Healey JS; Crystal E
    J Interv Card Electrophysiol; 2017 Oct; 50(1):57-63. PubMed ID: 28752228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of device-detected atrial high-rate episodes.
    Tomson TT; Passman R
    Card Electrophysiol Clin; 2015 Sep; 7(3):515-25. PubMed ID: 26304531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does atrial fibrillation detected by cardiac implantable electronic devices have clinical relevance?
    Glotzer TV; Ziegler PD
    Cardiol Clin; 2014 May; 32(2):271-81. PubMed ID: 24793802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.
    Glotzer TV; Ziegler PD
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S14-23. PubMed ID: 23790594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.